Lv11
40 积分 2025-06-02 加入
Targeting ADAR1 lactylation activates innate immune and overcomes chemoresistance in ovarian cancer
22分钟前
待确认
Long-Term Outcomes of Reduced-Dose Radiotherapy in Patients with Epstein-Barr Virus DNA-Selected Stage III Nasopharyngeal Carcinoma: A 5-Year Follow-Up Secondary Analysis of a Phase II Trial
5天前
已关闭
Long-Term Outcomes of Reduced-Dose Radiotherapy in Patients with Epstein-Barr Virus DNA-Selected Stage III Nasopharyngeal Carcinoma: A 5-Year Follow-Up Secondary Analysis of a Phase II Trial
5天前
已关闭
TRAPPC4 Promotes GPX4 Stability to Drive Ferroptosis Resistance and Tumor Progression in Head and Neck Squamous Cell Carcinoma
9天前
已完结
Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinoma
18天前
已关闭
Cisplatin in cancer treatment
29天前
已完结
Molecular mechanisms of cisplatin resistance
1个月前
已完结
An Oxidative Stress Nanoamplifier to Enhance the Efficacy of Cisplatin in Head and Neck Cancer
1个月前
已完结
STING-driven mitochondrial metabolism reverses cisplatin resistance via MDH2 desuccinylation in non-small cell lung cancer
1个月前
已完结
Platinum rechallenge in recurrent head and neck squamous cell carcinoma after primary chemoradiation
1个月前
已完结
皖公网安备34019202002308
